PLA2G2D antibody (C-Term)
Quick Overview for PLA2G2D antibody (C-Term) (ABIN954162)
Target
See all PLA2G2D AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 112-138, C-Term
-
Specificity
- This antibody recognizes Human PLA2G2D (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 112-138 amino acids from the C-terminal region of human PLA2G2D
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PLA2G2D (Phospholipase A2, Group IID (PLA2G2D))
-
Alternative Name
- PLA2G2D
-
Background
- Transposase-derived protein that may have nuclease activity (Potential). Does not have transposase activity.Synonyms: GIID sPLA2, Group IID secretory phospholipase A2, PLA2IID, Phosphatidylcholine 2-acylhydrolase 2D, Phospholipase A2 group IID, SPLASH, Secretory-type PLA stroma-associated homolog, sPLA2-IID
-
Molecular Weight
- 16546 Da
-
Gene ID
- 26279
-
NCBI Accession
- NP_036532
-
Pathways
- Inositol Metabolic Process
Target
-